LUMEN BIOSCIENCE, INC.
SEATTLE, WA · Founded 2017 · CIK 0001703612 · Biotech · Private
Genetically engineered spirulina that expresses virus-like particles (VLPs) as oral and intranasal vaccines
lumen.bio →- Grants
- $3.6M
- 6 awards
- Sector median: 1
- Raised
- $50M
- 5 Form D · Apr 2025
- 18 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 14 granted · 26 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201720182019202020212022202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Development of a Spirulina-based oral malaria vaccine | $299,904 | |
| Federal grant | Department of Agriculture · Spirulina-based Oral Vaccine For Infectious Hematopoietic Necrosis Virus (ihnv) In Farmed Salmonid Fish | $96,202 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of a Spirulina-based oral malaria vaccine | $297,071 | |
| Private capital raised | Form D · SEC | $26,052,323 | |
| Federal grant | Department of Health and Human Services · Phase II · Phase II STTR development of an intranasal/oral Spirulina-based PfCSP malaria vaccine. | $1,000,000 | |
| Private capital raised | Form D · SEC | $50,464,302 | |
| Federal grant | Department of Health and Human Services · Phase II · Phase II STTR development of an intranasal/oral Spirulina-based PfCSP malaria vaccine. | $1,000,000 | |
| Private capital raised | Form D · SEC | $33,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Phase II STTR development of an intranasal/oral Spirulina-based PfCSP malaria vaccine. | $925,300 | |
| Private capital raised | Form D · SEC | $18,345,489 | |
| Private capital raised | Form D · SEC | $23,000,000 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2749 | JME Group Associates Inc | — | — |
| 2750 | FELIX BIOTECHNOLOGY INC | — | — |
| 2751 | Small Molecule PPI Mimics LLC | — | — |
| 2752 | LUMEN BIOSCIENCE, INC. | — | $50M |
| 2753 | Bicycle Therapeutics | — | — |
| 2754 | Curevo Vaccine | — | — |
| 2755 | SERODOPA THERAPEUTICS INC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Erik AndersonDirector
- Craig BehnkeExecutive Officer
- Robert CarlsonDirector
- Brian FinrowDirector · Executive Officer · Promoter
- Mark LittonDirector
- Marcos MillaDirector
- John MorrowExecutive Officer
- Eric OrseExecutive Officer
- James RobertsDirector · Executive Officer · Promoter
- Ed SchlectDirector
- Don SchlosserExecutive Officer
Patents
- Recombinant Spirulina Expressing Scaffolds And Methods Of Utilizing The Sameapplication
- Arthrospira Platensis Non-parenteral Therapeutic Delivery Platformapplication
- Leptin Compositions And Methods Of Making And Using The Same To Support Weight Loss And/or Maintenanceapplication
- Methanolytic Agents And Methods Of Using The Sameapplication
- Arthrospira Platensis Non-parenteral Therapeutic Delivery Platformgranted
- Leptin Compositions And Methods Of Making And Using The Same To Support Weight Loss And/or Maintenancegranted
- Arthrospira Platensis Oral Vaccine Delivery Platformgranted
- Arthrospira Platensis Oral Vaccine Delivery Platformapplication
- Thermostable Phycobiliproteins Produced From Recombinant Arthrospiragranted
- Targeted Mutagenesis In Spirulinaapplication
- Targeted Mutagenesis In Spirulinagranted
- Constructs Comprising Single Domain Vhh Antibodies Against Sars COV-2application
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.